Research Support




Sydney Catalyst is pleased to partner with the NHMRC Clinical Trial Centre to offer biostatistics support to members of Sydney Catalyst. 

To be eligible, applicants must be a confirmed member of one of the formally recognised Sydney Catalyst Member groups and be working on a translational cancer research project. Members will be able to access up to 3 hours support free of charge.

For more information or to request a consultation please download the

Biostats Support for Members Factsheet and Request Form.


Sydney Catalyst Support for Project Grant Applications

Sydney Catalyst hopes to provide assistance to our members as they prepare for project grant applications.

Sydney Catalyst members already have a good record of success in project grant applications for example, in the 2012 NHMRC Project Grant round members secured more than $14M for at least 17 cancer research projects to be conducted over the next 3-5 years (more info). Support for member grant applications is in line with our overall goals and objectives, which include creating new and strengthening existing collaborations, as well as developing and supporting a strong translational cancer research program.


Creating new and strengthening existing collaborations

Sydney Catalyst has more than 500 members, all of whom have a primary focus in cancer research or treatment, and an incredibly broad range of research interests and expertise in translational research across the full continuum from basic biosciences, molecular biomarker discovery, descriptive research, clinical trials, psychosocial research and implementation research of best evidence-based care into practice. As such, our consortium is in an excellent position to contribute to and lead competitive research funding applications.

One way that we can help improve collaboration and communication across our group is by helping members to identify potential collaborators. We have a 'Find a Collaborator' search in the members' area of our website, which we are keen for our members to use to identify individuals and/or groups with specific expertise that might help strengthen planned applications. Similarly, we are also able to assist members who make contact with us directly to try and identify others who might be able to contribute individual projects. In doing so we hope to be able to improve collaboration and communication amongst our members, helping to assemble more competitive, truly multi-disciplinary project grant teams in translational cancer research.


Developing and supporting a strong translational cancer research program

Concept and/or project development

Sydney Catalyst has a small central team with expertise in concept and project development (incl. research design and operations, biostatistics, budget development and management etc.), who in turn have access to a larger group of senior investigators and leads (for example our T1/T2 and T2/T3 working groups). Members who are interested in obtaining advice and/or support in the development of individual concepts and projects are encouraged to make contact with us directly to discuss further. Where there is an agreed mutual interest and benefit, concept development support may be available.

Inclusion of Sydney Catalyst as a collaborating partner

There may be cases where a funding application is especially strengthened by the inclusion of Sydney Catalyst as a collaborating partner, or even as the lead group for a project. Making the most of our collective expertise and track record is another way that we can contribute to the development of a strong translational cancer research program. This could mean that the research work is coordinated by us centrally, but it is more likely to be work led by one of our member groups taking advantage of our central resources and infrastructure.


Other support? 

Sydney Catalyst has created an online presentation for members entitled: 'Writing Successful Grants for Translational Research.'

In addition to the above, there may be other ways that we can offer support to our members in their applications for funding, so please don't hesitate to make contact with us. We'd like to reiterate that our plan is work closely with our member groups, many of which have their own processes for identifying collaborators, concept and project development etc. We're not interested in duplicating effort, just keen to explore news ways that we can support our members and significantly contribute to high quality translational cancer research.